Mr. Pratap Sandhu reports

THE PRECISION PEPTIDE COMPANY QUADRUPLES U.S. TELEHEALTH FORMULARY TO 16 PRESCRIPTION THERAPIES ACROSS SEVEN THERAPY AREAS

The Precision Peptide Company Inc. has quadrupled its U.S. telehealth formulary to 16 prescription therapies across seven therapy areas, fewer than four months after launching nationwide telehealth access.

The expansion builds on the company's 503A sterile compounding agreement (see news release dated June 2, 2026), its prescription and telehealth infrastructure partnership (see news release dated June 9, 2026), and its consumer-facing telehealth website (see news release dated July 7, 2026).

The expanded formulary spans:

• Weight management, including GLP-1 protocols (semaglutide and tirzepatide) and Lipo-B;
• Performance and growth hormone support, including sermorelin;
• Recovery;
• Longevity and cellular health, including NAD+ and glutathione;
• Immune support;
• Cognitive health;
• Sexual wellness, including PT-141.

Alongside single therapies, the company has introduced stacked protocols: multitherapy programs that a clinician can tailor to a patient's goals and manage as a single continuing plan, rather than managing each therapy separately.

Patients complete a secure on-line health assessment, which is reviewed by a United States-licensed clinician to determine whether a therapy is clinically appropriate. Medications prescribed following clinical approval are compounded in the United States by a licensed 503A pharmacy and shipped directly to patients across all 50 U.S. states.

With 16 prescription therapies, including the recovery patch (its BPC-157 transdermal patch) and six oral and topical formulations, the company offers 23 products under one brand. The portfolio offers needle-free products, with other formats available.

Pratap Sandhu, chief executive officer of The Precision Peptide Company, commented: "In July, we opened the door with a handful of therapies. Four months later, we cover seven therapy areas with 16 prescription therapies, with stacked protocols. That is the platform we set out to build: one U.S. company where a customer can start with a needle-free patch, add a daily capsule and move into a clinician-prescribed program without ever leaving the brand. Breadth is what turns a first purchase into a long-term relationship, and we are not finished adding to it."

About The Precision Peptide Company Inc.

Precision Peptide Company is a publicly traded wellness company building a next-generation platform for high-quality peptide formulations. By combining scientific formulation and innovative delivery technologies, the company creates products at the intersection of biotechnology and scalable consumer wellness. Products are manufactured in an approved U.S. facility and distributed across North America.

We seek Safe Harbor.